Both in Biotechnology
Vaxcyte vs Kymera Therapeutics
Over the past year PCVX returned +63.6% and KYMR returned +88.9%; their daily moves had a correlation of 0.31.
PCVX +63.6% KYMR +88.9%Growth of $1, one year, split-adjusted
| Metric | PCVX | KYMR |
|---|---|---|
| Price | $56.69 | $110.51 |
| Market cap | $8.44B | $9.19B |
| Today | −2.71% | −1.33% |
| 1 month | −5.3% | −6.5% |
| 6 months | +3.1% | +39.0% |
| Year to date | +22.9% | +42.0% |
| 1 year | +66.8% | +96.5% |
| Revenue growth (YoY) | — | +466.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −94.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 87.5× |
| Net cash | $1.49B | $688.6M |
| Dividend yield | — | — |
| Volatility (60d) | 38.6% | 41.5% |
| Short % of float | 12.7% | 17.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).